Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 39

1.

Glypican-3-targeting F(ab')2 for 89Zr PET of hepatocellular carcinoma.

Sham JG, Kievit FM, Grierson JR, Chiarelli PA, Miyaoka RS, Zhang M, Yeung RS, Minoshima S, Park JO.

J Nucl Med. 2014 Dec;55(12):2032-7. doi: 10.2967/jnumed.114.145102. Epub 2014 Oct 30.

2.

Glypican-3-targeted 89Zr PET imaging of hepatocellular carcinoma.

Sham JG, Kievit FM, Grierson JR, Miyaoka RS, Yeh MM, Zhang M, Yeung RS, Minoshima S, Park JO.

J Nucl Med. 2014 May;55(5):799-804. doi: 10.2967/jnumed.113.132118. Epub 2014 Mar 13.

3.

Synthesis and in vitro evaluation of 5-fluoro-6-[(2-iminopyrrolidin-1-YL)methyl]uracil, TPI(F): an inhibitor of human thymidine phosphorylase (TP).

Grierson JR, Brockenbrough JS, Rasey JS, Wiens L, Vesselle H.

Nucleosides Nucleotides Nucleic Acids. 2010 Jan;29(1):49-54. doi: 10.1080/15257770903451603.

4.

A simple quantitative assay for the activity of thymidine kinase 1 in solid tumors.

Brockenbrough JS, Rasey JS, Grierson JR, Wiens LW, Vesselle H.

Nucl Med Biol. 2007 Aug;34(6):619-23.

PMID:
17707801
6.

Evaluation of 5'-deoxy-5'-[F-18]fluorothymidine as a tracer of intracellular thymidine phosphorylase activity.

Grierson JR, Brockenbrough JS, Rasey JS, Wiens LW, Schwartz JL, Jordan R, Vesselle H.

Nucl Med Biol. 2007 Jul;34(5):471-8. Epub 2007 May 11.

PMID:
17591546
7.

Kinetic analysis of 3'-deoxy-3'-18F-fluorothymidine in patients with gliomas.

Muzi M, Spence AM, O'Sullivan F, Mankoff DA, Wells JM, Grierson JR, Link JM, Krohn KA.

J Nucl Med. 2006 Oct;47(10):1612-21.

8.

Tumor hypoxia imaging with [F-18] fluoromisonidazole positron emission tomography in head and neck cancer.

Rajendran JG, Schwartz DL, O'Sullivan J, Peterson LM, Ng P, Scharnhorst J, Grierson JR, Krohn KA.

Clin Cancer Res. 2006 Sep 15;12(18):5435-41.

9.

Evaluation of 18F-annexin V as a PET imaging agent in an animal model of apoptosis.

Yagle KJ, Eary JF, Tait JF, Grierson JR, Link JM, Lewellen B, Gibson DF, Krohn KA.

J Nucl Med. 2005 Apr;46(4):658-66.

10.

Kinetic modeling of 3'-deoxy-3'-fluorothymidine in somatic tumors: mathematical studies.

Muzi M, Mankoff DA, Grierson JR, Wells JM, Vesselle H, Krohn KA.

J Nucl Med. 2005 Feb;46(2):371-80.

11.

Kinetic analysis of 3'-deoxy-3'-fluorothymidine PET studies: validation studies in patients with lung cancer.

Muzi M, Vesselle H, Grierson JR, Mankoff DA, Schmidt RA, Peterson L, Wells JM, Krohn KA.

J Nucl Med. 2005 Feb;46(2):274-82.

12.

Metabolism of 3'-deoxy-3'-[F-18]fluorothymidine in proliferating A549 cells: validations for positron emission tomography.

Grierson JR, Schwartz JL, Muzi M, Jordan R, Krohn KA.

Nucl Med Biol. 2004 Oct;31(7):829-37.

PMID:
15464384
13.

Effect of p53 activation on cell growth, thymidine kinase-1 activity, and 3'-deoxy-3'fluorothymidine uptake.

Schwartz JL, Tamura Y, Jordan R, Grierson JR, Krohn KA.

Nucl Med Biol. 2004 May;31(4):419-23.

PMID:
15093811
14.

Production of [F-18]fluoroannexin for imaging apoptosis with PET.

Grierson JR, Yagle KJ, Eary JF, Tait JF, Gibson DF, Lewellen B, Link JM, Krohn KA.

Bioconjug Chem. 2004 Mar-Apr;15(2):373-9.

PMID:
15025534
15.

Monitoring tumor cell proliferation by targeting DNA synthetic processes with thymidine and thymidine analogs.

Schwartz JL, Tamura Y, Jordan R, Grierson JR, Krohn KA.

J Nucl Med. 2003 Dec;44(12):2027-32.

16.

Kinetics of 3'-deoxy-3'-[F-18]fluorothymidine uptake and retention in dogs.

Shields AF, Grierson JR, Muzik O, Stayanoff JC, Lawhorn-Crews JM, Obradovich JE, Mangner TJ.

Mol Imaging Biol. 2002 Jan;4(1):83-9.

PMID:
14538051
17.

[(18)F]FMISO and [(18)F]FDG PET imaging in soft tissue sarcomas: correlation of hypoxia, metabolism and VEGF expression.

Rajendran JG, Wilson DC, Conrad EU, Peterson LM, Bruckner JD, Rasey JS, Chin LK, Hofstrand PD, Grierson JR, Eary JF, Krohn KA.

Eur J Nucl Med Mol Imaging. 2003 May;30(5):695-704. Epub 2003 Mar 11.

PMID:
12632200
18.

Validation of FLT uptake as a measure of thymidine kinase-1 activity in A549 carcinoma cells.

Rasey JS, Grierson JR, Wiens LW, Kolb PD, Schwartz JL.

J Nucl Med. 2002 Sep;43(9):1210-7.

19.

New routes to N-alkylated cyclic sulfamidates.

Posakony JJ, Grierson JR, Tewson TJ.

J Org Chem. 2002 Jul 26;67(15):5164-9.

PMID:
12126401
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk